| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4135472 | A | Cytotoxicity against human HL cells assessed as cell viability at 50 uM after 72 hrs by resazurin dye based fluorescence assay relative to control | Homo sapiens | 53 | cell-based format | Scientific Literature | ||
| 2. | ALA4135473 | F | Antichlamydial activity against Chlamydia pneumoniae K7 infected in HL cells assessed as chlamydial inhibition at 50 uM after 70 hrs by fluorescent microscopic analysis | Chlamydia pneumoniae | 26 | organism-based format | Scientific Literature | ||
| 3. | ALA4135474 | F | Antichlamydial activity against Chlamydia pneumoniae K7 infected in HL cells after 70 hrs by fluorescent microscopic analysis | Chlamydia pneumoniae | 7 | organism-based format | Scientific Literature | ||
| 4. | ALA5145690 | F | Antitumor activity against mouse B16-F10 cells bearing C57BL/6 mouse assessed as reduction in tumor weight at 20 mg/kg, po administered once daily for consecutive 5 days relative to control | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA5145691 | F | Antitumor activity against mouse B16-F10 cells bearing C57BL/6 mouse assessed as reduction in tumor weight at 40 mg/kg, po administered once daily for consecutive 5 days relative to control | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA5145692 | F | Antitumor activity against mouse B16-F10 cells bearing C57BL/6 mouse assessed as reduction in tumor weight at 20 mg/kg, sc administered once daily for consecutive 5 days relative to control (Rvb = 50.7%) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA5145693 | F | Antitumor activity against mouse B16-F10 cells bearing C57BL/6 mouse assessed as reduction in tumor weight at 40 mg/kg, sc administered once daily for consecutive 5 days relative to control (Rvb = 50.7%) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA5145694 | F | Antitumor activity against mouse B16-F10 cells bearing C57BL/6 mouse assessed as reduction in tumor weight at 20 mg/kg, ip administered once daily for consecutive 5 days relative to control (Rvb = 71.1%) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA5145695 | F | Antitumor activity against mouse B16-F10 cells bearing C57BL/6 mouse assessed as reduction in tumor weight at 40 mg/kg, ip administered once daily for consecutive 5 days relative to control (Rvb = 71.1%) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA5145696 | F | Antitumor activity against mouse B16-F10 cells bearing C57BL/6 mouse assessed as reduction in mitotic figures at 40 mg/kg, ip administered once daily for consecutive 5 days by H and E staining microscopic analysis | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA5145697 | F | Antitumor activity against mouse B16-F10 cells bearing C57BL/6 mouse assessed as reduction in tumor weight at 20 mg/kg, po administered once daily for consecutive 5 days in presence of cisplatin relative to control | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA5145698 | F | Antitumor activity against mouse B16-F10 cells bearing C57BL/6 mouse assessed as reduction in number of mitotic figures at 20 mg/kg, po administered once daily for consecutive 5 days in presence of cisplatin by H and E staining microscopic analysis | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA5145699 | F | Antitumor activity against mouse B16-F10 cells bearing C57BL/6 mouse bearing assessed as change in cleaved caspase-3 level in tumor at 20 mg/kg, po administered once daily for consecutive 5 days by immunostaining analysis | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA5145700 | T | Toxicity in C57BL/6 mouse xenografted with mouse B16-F10 cells assessed as change in body weight at 20 to 40 mg/kg, po administered once daily for consecutive 5 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA5145701 | T | Toxicity in C57BL/6 mouse xenografted with mouse B16-F10 cells assessed as change in body weight at 20 to 40 mg/kg, ip administered once daily for consecutive 5 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA5145702 | T | Toxicity in C57BL/6 mouse xenografted with mouse B16-F10 cells assessed as change in body weight at 20 to 40 mg/kg, sc administered once daily for consecutive 5 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA5145703 | T | Toxicity in C57BL/6 mouse xenografted with mouse B16-F10 cells assessed as splenomegaly at 40 mg/kg, po administered once daily for consecutive 5 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA5145704 | T | Toxicity in C57BL/6 mouse xenografted with mouse B16-F10 cells assessed as splenomegaly at 40 mg/kg, ip administered once daily for consecutive 5 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA5145705 | T | Toxicity in C57BL/6 mouse xenografted with mouse B16-F10 cells assessed as splenomegaly at 40 mg/kg, sc administered once daily for consecutive 5 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA5145706 | T | Toxicity in C57BL/6 mouse xenografted with mouse B16-F10 cells assessed as splenomegaly at 20 mg/kg, ip administered once daily for consecutive 5 days | Mus musculus | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!